Recent advances in hypoxia-activated compounds for cancer diagnosis and treatment

Xiaoyu Yuan,Zhiying Xie,Taotao Zou

DOI: https://doi.org/10.1016/j.bioorg.2024.107161

IF: 5.307

2024-03-01

Bioorganic Chemistry

Abstract:Hypoxia, as a prevalent feature of solid tumors, is correlated with tumorigenesis, proliferation, and invasion, playing an important role in mediating the drug resistance and affecting the cancer treatment outcomes. Due to the distinct oxygen levels between tumor and normal tissues, hypoxia-targeted therapy has attracted significant attention. The hypoxia-activated compounds mainly depend on reducible organic groups including azo, nitro, N-oxides, quinones and azide as well as some redox-active metal complex that are selectively converted into active species by the increased reduction potential under tumor hypoxia. In this review, we briefly summarized our current understanding on hypoxia-activated compounds with a particular highlight on the recently developed prodrugs and fluorescent probes for tumor treatment and diagnosis. We have also discussed the challenges and perspectives of small molecule-based hypoxia-activatable prodrug for future development.

biochemistry & molecular biology,chemistry, organic